Universe Pharmaceuticals

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 25, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024.

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024

Universe Pharmaceuticals (NASDAQ: UPC ) stock is falling on Tuesday after the company's shares experienced a rally during the prior day of trading. Shares of UPC closed out Friday up 43.9% without any clear news from the traditional Chinese medicine company.

Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?

JI'AN, China, Jan. 30, 2024 /PRNewswire/ -- Universe Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2023. Mr. Gang Lai, Chairman and Chief Executive Officer of Universe Pharmaceuticals, commented, "Despite market fluctuations and the economic slowdown impacting our business in fiscal year 2023, we continued our efforts to deliver high quality products to our loyal customers.

Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results

Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq Global Market.

Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the Company's issued and unissued share capital into one (1) ordinary share with par value of US$0.01875 (the “Share Consolidation”). As a result of the Share Consolidation, each six (6) pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.

Universe Pharmaceuticals INC Announces Share Consolidation

JI'AN, China, Aug. 16, 2022 /PRNewswire/ -- Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2022 ended March 31, 2022. Mr. Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, commented, "During the first six months of fiscal year 2022, we have navigated business uncertainties and adjusted our business strategy to offset the impact of reduced product sales volume due to the resurgence of COVID-19 cases and related lockdowns.

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022

Ji'an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Lian-Ou Health Pharmaceutical (Guangzhou) Co., Ltd. (“Lian-Ou Health”), a high-tech company focusing on pharmaceuticals, technology, operation, sales, and services, to develop the Company's digital marketing and expand its sales channels on e-commerce platforms.

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Ji'an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Jinggangshan University (“JGSU”), a public university located in Ji'an City of Jiangxi Province, for a study on the chemical constituents of Liparis Odorata, a traditional Chinese medicine, for the treatment of hyperlipidemia.

Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine

Ji'an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company appointed Mr. Baochang Liu as its Chief Operating Officer, effective December 1, 2021.

Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer

Ji'an, Jiangxi, China, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on December 1, 2021 the Company entered into a strategic cooperation agreement and associated ancillary agreements (the “Agreements”) with Kitanihon Pharmaceutical Co., Ltd. (“KP”), a Japanese company engaged in the research, development, manufacturing, and distribution of Kampo (a traditional Japanese herbal medicine) pharmaceutical and medical products. The purpose of the Agreements is to address market demand for Kampo medicine and high-end traditional Chinese medicine (“TCM”).

Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine

The stock price of Universe Pharmaceuticals Inc (NASDAQ: UPC) increased by over 7% during intraday trading. This is why it happened.

UPC Stock Increases Over 7% Intraday: Why It Happened

Ji'an, Jiangxi, China, July 30, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that it will release its unaudited financial results for the first six months of fiscal year 2021 ended March 31, 2021 on Monday, August 2, 2021 before the market opens. The Company intends to file its financial results on Form 6-K with the Securities and Exchange Commission and release its earnings press release accordingly.

Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021

The stock price of Universe Pharmaceuticals Inc (NASDAQ: UPC) increased by over 9% pre-market. This is why it happened.

UPC Stock Increases Over 9% Pre-Market: Why It Happened

The stock price of Universe Pharmaceuticals Inc (NASDAQ: UPC) increased 28.72% after hours. These are some details you should know.

UPC Stock Increased 28.72% After Hours: Details You Should Know

Here's why UPC stock is surging today on news that a broker leading the deal exercised its over-allotment option, in a surprising move. The post UPC Stock: Why Universe Pharmaceuticals Is Popping Higher Today appeared first on InvestorPlace.

UPC Stock: Why Universe Pharmaceuticals Is Popping Higher Today

The stock price of Universe Pharmaceuticals Inc (Nasdaq: UPC) increased by over 80% during intraday trading. This is why it happened.

Universe Pharmaceuticals Stock Price Increased Over 80% Intraday: Why It Happened

Ji'an, Jiangxi, China, March 31, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the underwriter of its previously announced initial public offering of ordinary shares (the "Offering") has exercised in full its option to purchase an additional 750,000 ordinary shares at the public offering price of $5.00 per share to cover overallotments, resulting in additional gross proceeds of $3.75 million. After giving effect to the full exercise of the over-allotment option, the total number of shares sold by the Company in the Offering increased to 5.75 million shares and gross proceeds increased to $28.75 million. The exercise of the over-allotment option has closed on March 31, 2021.

Universe Pharmaceuticals INC Announces Full Exercise of Underwriter's Over-Allotment Option in the Public Offering

China Pharma Holdings

Cyanotech

SeaChange International

Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks appeared first on InvestorPlace.

Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks

Universe Pharmaceuticals (UPC) stock is soaring higher in early trading Monday morning despite a lack of news concerning the Chinese company. The post UPC Stock: 10 Things to Know as Universe Pharmaceuticals Rockets Higher appeared first on InvestorPlace.

UPC Stock: 10 Things to Know as Universe Pharmaceuticals Rockets Higher

The stock price of Universe Pharmaceuticals Inc (NASDAQ: UPC) has increased by over 200% pre-market. This is why it happened.

UPC Stock Price Increased Over 200% Pre-Market: Why It Happened

Ji'an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing of its initial public offering (“Offering”) of 5,000,000 ordinary shares at a public offering price of US$5.00 per ordinary share.

Universe Pharmaceuticals INC Announces Closing of Initial Public Offering

Ji'an, Jiangxi, China, March 23, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”), a pharmaceutical producer and distributor in China, today announced the pricing of its initial public offering (“Offering”) of 5,000,000 ordinary shares at a public offering price of US$5.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Global Market and commenced trading today under the ticker symbol “UPC”.

News for Universe Pharmaceuticals Stock (UPC)